James Fitzgerald, MD
Urology · North Easton, MANPI 1841297710
Payments from drug & device makers
Across 513 payments — averaging $30.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Astellas Pharma US Inc$2K
- Neotract Inc.$2K
- Johnson & Johnson$992
- Endo Pharmaceuticals Inc.$713
- Antares Pharma, Inc.$711
- plus $8K from 53 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$15,590 in reported general payments places this provider in the 85th percentile of 327 urology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in North Easton
- Padraic McCahillNorth Easton$12K
- Natalya LopushnyanNorth Easton$12K
- Ryan FrankelNorth Easton$11K
- Christopher CutieBoston$3.5M
- Henry MitchesonWatertown$1.6M
- Brian EisnerBoston$1.4M
- Mark PrestonBoston$1.2M
- David StaskinBrighton$807K
- Abraham MorgentalerChestnut Hill$522K
- Alejandro SanchezBoston$349K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.